Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/12/2023
Review of Chinese Biopharma Industry Performance in September 2023
10/4/2023
Sales Expenses of 489 Chinese Pharma Cos Exceed CNY 170B in H1/2023
9/20/2023
A Share-Listed Chinese MedPharm Cos Report Broadly Positive Performanc...
8/30/2023
Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
8/25/2023
IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
8/24/2023
Review of China Performance of Leading MNCs in China H1/2023 (Updated)
7/5/2023
SMEI Forecasts Growth of Ex-Hospital and Innovative Drug Sales Before ...
7/3/2023
Innovative Drug Market Share on the Rise Continuously in Recent Years:...
6/15/2023
Top Ten Listed Chinese Pharma Companies by R&D Spending in 2021/2022
6/1/2023
NH's DB6: China's Consumer Healthcare Market Underperformed in 2022
6/1/2023
NH's DB6: Top Ten Chinese CHC Brands in 2021
6/1/2023
NH's DB6: Chinese Consumer Healthcare Market Forecast 2027/2032
6/1/2023
Edelman Report Finds Chinese Trusting Pharma the Most
5/29/2023
A Share-Listed Chinese MedPharm Cos Report Performance in 2022 with Ov...
5/29/2023
Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2022
5/22/2023
SMEI: Chinese Terminal Drug Market Growth Slowed to 1.1% in 2022 (Upda...
5/18/2023
Chinese A Shared-listed Pharma Companies Report Mixed Q1/2023 Performa...
5/16/2023
China's Top 10 Homegrown Novel Drugs in 2022, Vaccines and Cancer Drug...
4/21/2023
NMPA Issues the 2022 Drug Regulatory Statistics Annual Report
4/12/2023
Yicai: Most Chinese Regions Eye Healthcare Industry Upgrades
4/12/2023
Outlook of China's Health Systems (Informa)
4/1/2023
China Further Intensifies Healthcare Cost Containment and Price Contro...
3/29/2023
Investing in China's Healthcare Sector (China Briefing)
3/15/2023
Deloitte: 2023 China LSHC Investment and M&A Market Outlook
3/9/2023
PhIIC: Chinese Retail Pharmacy Sales Fell Sharply in 2022 Despite Rebo...
2/24/2023
SMEI: Chinese Pharma Revenues Down 1.6% Last Year But Expected to Rebo...
2/24/2023
IQVIA: Chinese Hospital Drug Market Shrank 2.1% in 2022
2/16/2023
IQVIA: Chinese Pharma to See 2%-5% CAGR Before 2027
2/10/2023
China Drug Sales Performance of Top Seven MNC Pharma Cos in 2022
2/2/2023
Performance of A Share-listed MedPharm Cos Mixed in 2022
Page:
3
/
22
Total number of articles:
640
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit